Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07187466 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease

Study acronym: SQUARE PD
StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Jul 1, 2026 to Oct 1, 2026v5
  2. Start date: Apr 1, 2026 to Jul 1, 2026v4
  3. Start date: Jan 1, 2026 to Apr 1, 2026v3
  4. Study title shortened, about 2 wordsv2 See this version in full on ClinicalTrials.gov ↗
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to learn about different treatments for overactive bladder symptoms in Parkinson's Disease. The investigators want to find out if people who do not respond to one treatment (either behavioral or drug treatment) will respond to combined treatment. The investigators also want to find out what factors influence whether someone responds to the treatments.
Trial Details
NCT Number NCT07187466
Lead Sponsor VA Office of Research and Development
Conditions Overactive Bladder, Parkinson Disease
Enrollment 146 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov